High purity (99%), suitable for reproducible laboratory experiments
Very low LDL (below 50-70 mg/dL) achieved through aggressive medication raises theoretical concerns about reduced hormone production, potential cognitive effects, and increased hemorrhagic stroke risk in some populations
The weightloss injection does not change this
However, for some, there is a dark side to semaglutide that includes high costs, medication shortages and the potential for severe side effects
In a 4-week, placebo-controlled trial of VYVANSE in pediatric patients ages 6 to 12 years old with ADHD, there was a dose-related decrease in weight in the VYVANSE groups compared to weight gain in the placebo group
Detaljnije o ceni leka Wegowy u Srbiji